𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Renal transport mechanisms for xenobiotics: chemicals and drugs

✍ Scribed by Ullrich, K.J. ;Rumrich, G.


Book ID
104657164
Publisher
Springer-Verlag
Year
1993
Tongue
English
Weight
599 KB
Volume
71
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.

✦ Synopsis


Using the stopped flow tubular lumen or peritubular capillary microperfusion method, the apparent K i values of a large number of organic anions and cations against the respective transport systems were evaluated. Thereby the luminal transport system for monocarboxylates (lactate), the contraluminal and luminal transport systems for dicarboxylates (succinate), sulfate, and hydrophobic organic cations (tetraethylammonium or N 1methyl-nicotinamide), as well as contraluminal transport system for hydrophobic organic anions (para-aminohippurate, PAH) were characterized and their specificity determined. There is a partially overlapping substrate specificity between the PAH, dicarboxylate, and sulfate transport systems but also between the PAH and organic cation transport system. Xenobiotics and their metabolites are transported mainly by the organic anion (PAH) and organic cation transport systems. To test the complicated interactions possible a shot injection/ urinary excretion method with simultaneous measurement of the intracellular concentration was developed. With this approach it is possible to evaluate (a) whether a substrate is net secreted or net reabsorbed, (b) whether interference with other substrates occurs, (c) whether interference takes place at the luminal or contraluminal cell side, and (d) whether cis-inhibition or trans-stimulation is the predominant mode of interaction. Finally, it will be discussed which ability a substrate must have to penetrate the cell membrane via a transporter, through the lipid bilayer, or both.


πŸ“œ SIMILAR VOLUMES


Role of xenobiotic transporters in bacte
✍ Kunihiko Nishino; Akihito Yamaguchi πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 264 KB

## Abstract Since the discovery of antibiotic therapeutics, the battles between humans and infectious diseases have never been stopped. Humans always face the appearance of a new bacterial drug‐resistant strain followed by new antibiotic development. However, as the genome sequences of infectious b